期刊文献+

血纤溶活性变化对颈动脉粥样硬化和急性脑梗死患者的影响和分析 被引量:4

The Lever of Plasma Fibrinogen in Carotid Atherosclerosis and Acute Cerebral Infarction
原文传递
导出
摘要 目的:研究血纤溶活性变化对颈动脉粥样硬化患者和急性脑梗死患者的影响。方法:67例急性脑梗死患者(ACI组)和62名健康体检老年人(对照组),均行彩色多普勒超声诊断仪超声观察颈动脉有无斑块;同时测定血浆组织型纤溶酶原激活物(t-PA)和纤溶酶原激活物抑制物-1(PAI-1)的活性。结果:对照组中有颈动脉斑块者与无颈动脉斑块者相比,血浆t-PA降低,PAI-1升高,P/t值升高(P<0.05);观察组颈动脉斑块发生率明显高于对照组(P<0.05);观察组患者急性期血浆t-PA、PAI-1升高,P/t值减少(P<0.05)。结论:颈动脉硬化时,机体纤溶活性处于减低状态;急性脑梗死发生时,纤溶活性处于相对亢进状态。 Aim. To study the plasma fibrinogen level in the patients with carotid atherosclerosis(AS) and acute cerebral infarction(ACI). Methods: Blood samples were collected from 67 patients with ACI and 62 controls. The level of tissue-type plasminogen activator(t-PA) and plasminogen activator inhibitor-1 (PAI-1) were tested with ELISA. The carotid was observed by B-mode ultrasound. Results: The plasma t-PA was lower and the PAI-1 was higher in carotid atherosclerosis (P〈0.05) .The concentrations of plasma t-PA and PAI-1 were higher in ACI group (P〈0.05). Conclusion: The relative decrease of fibrinolytic activity was the feature of the patients with carotid atherosclerosis, and relative increase of fibrinolytic activity with ACI.
出处 《中国临床神经科学》 2008年第3期242-245,共4页 Chinese Journal of Clinical Neurosciences
基金 福建省科技基金项目号(No.2001Z158)
关键词 动脉粥样硬化 脑梗死 组织型纤溶酶原激活物 纤溶酶原激活物抑制物-1 血浆 atherosclerosis cerebral infarction tissue-type plasminogen activator plasminogen activator inhibitor-1 blood plasma
  • 相关文献

参考文献7

二级参考文献26

  • 1各类脑血管疾病诊断要点[J].中华神经科杂志,1996,29(6):379-380. 被引量:33058
  • 2张波,张秋滨,韩荣河,姚玉虹,何宏,唐强,纪晓军.脑血管病患者急性期血浆t-PA、PAI活性的研究[J].铁道医学,1997,25(1):32-33. 被引量:8
  • 3张学勤,左大鹏,王秋萍,路阳,鞠淑英.急性脑卒中血浆纤溶状态的动态观察[J].中风与神经疾病杂志,1997,14(1):16-17. 被引量:37
  • 4Lindgren A, Lindoff C, Norrving B, et al. Tissue plasminogen activator and plasminogen activator inhibitor - 1 in stroke patients [ J ]. Stroke, 1996,27(6) : 1066 - 1071.
  • 5Gertler JP, Perry L, L'Talien G, et al. Ambient oxygen tension modulates endo- thelial fibrinolysis[J].J Vasc Surg, 1998,18 (6) :939 - 946.
  • 6Margaglione M, Di Minno G, Grandone E, et al. Abnormally high circulation levels of tissue plasminogen activator and plasminogen activator inhibitor-1 in patients with a history of ischemia stroke [J].Arteriosderosis Thromb,1996,16( 11 ) :1741 - 1745.
  • 7Zhang YD, Shi JP, Li ZH, et al. Analysis of risk factors for recurrent cerebral infarction [ J ]. Neurol, 1998,245 ( 6-7 ) :373 - 380.
  • 8Hernandez Nunez A, Romero Barbero JL, Caceres Sansaloni A, et al. Altera- tions of fibfinolysis in stroke[J].An Med Intena 1996,13 (3) :107 -110.
  • 9Brockmann MJ, Schwendemann G, Stief TW. Plasminogen activator inhibitor in acute stroke [ J ]. Mol Chem Neuropathol, 1991,14 ( 2 ) : 143 -150.
  • 10Yamada S, Yamada R, Ishii A, et al. t-PA activity, antigen and PAl-1 antigen levels in blood obtained from the patients with cerebral infarction[ J]. Rinsho Byori,1990,38:(7)819 -824.

共引文献84

同被引文献36

引证文献4

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部